STVN
HealthcareStevanato Group S.p.A.
$21.05
+$0.47 (+2.28%)
Jan 5, 2026
Price History (1Y)
Analysis
Stevanato Group S.p.A. (STVN) is a healthcare company operating in the medical instruments and supplies industry. With a market capitalization of $5.75B and revenue of $1.17B, it has a significant presence in its sector. The company employs 5521 individuals. Financially, Stevanato Group S.p.A. demonstrates moderate profitability with gross, operating, and profit margins at 28.7%, 17.7%, and 12.0% respectively. Returns on equity and assets stand at 10.2% and 5.4%. The company's balance sheet shows a debt-to-equity ratio of 31.41 and a current ratio of 1.89, indicating manageable debt levels relative to its cash position, which is $119.30M. Valuation metrics for Stevanato Group S.p.A. include a price-to-earnings (P/E) ratio of 34.51 (TTM) and 28.54 (forward), with an earnings growth rate of 18.2% year-over-year. The company's dividend yield is 31.0%, accompanied by a payout ratio of 10.6%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Stevanato Group S.p.A.
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide solutions for biopharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. It operates through two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. The company offers drug containment solutions comprising pre-fillable syringes, cartridges, vials, and ampoules; in-vitro diagnostic solutions; drug delivery systems, including pen injectors, auto-injectors, and wearable injectors; diagnostic laboratory consumables; analytical and regulatory support services; medical devices; pharmaceutical visual inspection machines; assembling and packaging machines; glass forming machines; and after-sales services, such as spare parts and maintenance services. It also provides contract development and manufacturing services for customer-owned drug delivery devices. The company serves pharmaceutical, biotechnology, diagnostics, and life sciences companies; and drug product, glass packaging, and fill and finish contract manufacturers. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
Visit website →Key Statistics
- Market Cap
- $5.75B
- P/E Ratio
- 34.51
- 52-Week High
- $28.00
- 52-Week Low
- $17.81
- Avg Volume
- 296.89K
- Beta
- 0.58
- Dividend Yield
- 31.00%
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NYQ
- Country
- Italy
- Employees
- 5,521